Vertex Pharmaceuticals, Inc. (VRTX)
464.86
-5.66
(-1.20%)
USD |
NASDAQ |
Feb 05, 13:02
Vertex Pharmaceuticals EPS Diluted (Quarterly) : 4.204 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Amgen, Inc. | 2.45 |
| Eli Lilly & Co. | 7.390 |
| Merck & Co., Inc. | 1.191 |
| Regeneron Pharmaceuticals, Inc. | 7.86 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.083B |
| Revenue (Quarterly) | 3.115B |
| Total Expenses (Quarterly) | 2.032B |
| Enterprise Value | 114.92B |
| Gross Profit Margin (Quarterly) | 86.69% |
| Profit Margin (Quarterly) | 34.76% |
| Earnings Yield | 3.05% |
| Operating Earnings Yield | 3.76% |
| Normalized Earnings Yield | 3.366 |